HAIs represent a substantial clinical and financial burden on European countries


Over 1 in 20 patients entering hospital in Europe acquire an HAI resulting in over
3.5 million

in the European Union (EU) per year29

patients die as a direct consequence of these infections in the EU 29

HAIs generate approximately
16.4 million

extra hospital days per year and the estimated cost of HAI is conservatively estimated to be
5.48 billion30




Challenges in HAI

Infection prevention & treatment

Helping to reduce risk of infection across the patient journey, from sample collection and diagnostics to drug delivery and treatment, supporting prevention of further spread of pathogens.

Screening & Diagnostics
More rapid, accurate and appropriate diagnostic identification to enable more effective clinical decision-making including measures to appropriately isolate and/or target and treat patients.

Prevention of catheter-associated bloodstream infections
Reducing the risk of infections and complications associated with vascular access by enhancing the compliance with guidelines, protocols and regulation, optimizing workflow, promoting standardization, and improving process efficiencies.

Sample collection
Improved sample quality resulting in faster and more consistent results, greater diagnostic accuracy, prevention of sample collection errors, and poor quality samples and retesting.

Surveillance and reporting
Using a digital infrastructure to accelerate remote multi-site diagnostic results availability between the lab and second location. Enables faster decisions about antibiotic therapy. Allows for surveillance of epidemiological trends.

Prevention of postoperative wound infections
Minimising the risk of surgical-site infections through best practice patient preoperative skin preparation and disinfection

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.

Get in touch